Robert Peter Gale
#183,064
Most Influential Person Now
Robert Peter Gale's AcademicInfluence.com Rankings
Robert Peter Galephilosophy Degrees
Philosophy
#11594
World Rank
#15999
Historical Rank
Logic
#8400
World Rank
#10508
Historical Rank
Robert Peter Galebiology Degrees
Biology
#15350
World Rank
#19308
Historical Rank
Immunology
#1059
World Rank
#1085
Historical Rank
Microbiology
#1026
World Rank
#1144
Historical Rank
Download Badge
Philosophy Biology
Why Is Robert Peter Gale Influential?
(Suggest an Edit or Addition)Robert Peter Gale's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. (1984) (605)
- Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial. (1983) (307)
- Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy. (1983) (256)
- Stress increases metastatic spread of a mammary tumor in rats: Evidence for mediation by the immune system (1991) (241)
- Clinical uses of intravenous immunoglobulins. (1988) (225)
- Involvement of brain opiate receptors in the immune-suppressive effect of morphine. (1986) (222)
- Human B-lymphocyte antigens expressed by lymphocytic and myelocytic leukemia cells. I. Detection by rabbit antisera (1976) (202)
- Pomalidomide is active in the treatment of anemia associated with myelofibrosis. (2009) (198)
- Stress, opioid peptides, the immune system, and cancer. (1985) (167)
- Treatment of acute myelogenous leukemia. A prospective controlled trial of bone marrow transplantation versus consolidation chemotherapy. (1985) (159)
- Trimethoprim-sulfamethoxazole for the treatment of Pneumocystis carinii pneumonia. (1980) (148)
- Bone marrow transplantation after the Chernobyl nuclear accident. (1989) (147)
- Polymorphonuclear leukocytes in antibody-dependent cellular cytotoxicity. (1975) (147)
- Therapeutic granulocyte transfusions for documented infections. A controlled trial in ninety-five infectious granulocytopenic episodes. (1982) (146)
- A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia. (1981) (138)
- Apparent involvement of opioid peptides in stress-induced enhancement of tumor growth (1983) (130)
- Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients. (1984) (116)
- Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients. (1990) (113)
- Intravenous immunoglobulins as therapeutic agents. (1987) (106)
- Aplastic anemia and non-A, non-B hepatitis. (1983) (102)
- Long-Term Follow-up of Adults with Acute Lymphoblastic Leukemia in First Remission Treated with Chemotherapy or Bone Marrow Transplantation (1995) (89)
- Effects of a single administration of morphine or footshock stress on natural killer cell cytotoxicity (1987) (88)
- Stress and morphine affect survival of rats challenged with a mammary ascites tumor (MAT 13762B). (1983) (88)
- The mutational spectrum of brachydactyly type C. (2002) (83)
- Immunoblastic sarcoma in donor cells after bone-marrow transplantation. (1979) (79)
- Modulation of polymorphonuclear leukocyte-mediated antibody-dependent cellular cytotoxicity. (1974) (73)
- Aplastic anemia: biology and treatment. (1981) (69)
- Gene Markers in Human Bone Marrow Transplantation 1 (1977) (59)
- Veno‐occlusive disease of the liver after high‐dose mitomycin C therapy and autologous bone marrow transplantation (1982) (58)
- Piperacillin plus amikacin therapy v carbenicillin plus amikacin therapy in febrile, granulocytopenic patients. (1982) (56)
- Ethanol increases tumor progression in rats: Possible involvement of natural killer cells (1992) (50)
- Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients. (1986) (49)
- Prophylactic granulocyte transfusions during chemotherapy of acute nonlymphocytic leukemia. (1981) (43)
- The role of immunotherapy in acute myelogenous leukemia. (1983) (43)
- Immune interventions in disease. (1987) (39)
- Antibody dependent cellular cytotoxicity: cytotoxicity mediated by non t-lymphocytes. (1974) (37)
- Antibody synthesis by bone marrow cells in vitro following primary and booster tetanus toxoid immunization in humans. (1984) (36)
- Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients. (1988) (35)
- Immunologic defects in young male patients with hepatitis-associated aplastic anemia. (1984) (35)
- Are We Prepared for Nuclear Terrorism? (2018) (34)
- Bacterial pyomyositis in a patient with aplastic anaemia. (1980) (27)
- Autotransplantation in lymphoma: better therapy or healthier patients? (1991) (26)
- A comparison of human lymphoid cells in antibody-dependent cellular cytotoxicity (ADCC). (1975) (25)
- Involvement of opioid peptides in the analgesic, immunosuppressive, and tumor-enhancing effects of stress. (1985) (24)
- POLYMORPHONUCLEAR LEUKOCYTE Fc RECEPTORS IN ANTIBODY‐DEPENDENT CELLULAR CYTOTOXICITY (ADCC) (1976) (23)
- Endogenous opioids may mediate the effects of stress on tumor growth and immune function. (1983) (23)
- Use of intravenous immunoglobulin to prevent or treat infections in persons with immune deficiency. (1997) (22)
- Leukemia-associated antigens detected by heterologous antisera. (1976) (20)
- Analysis of BCR‐ABL mRNA in chronic myelogenous leukemia patients and identification of a new BCR‐related sequence in human DNA (1989) (20)
- Neutrophil Function in Bone Marrow Transplant Recipients (1977) (16)
- Stress, Opioid Peptides and Immune Function (1986) (15)
- Cell surface antigens detected on mature and leukemic granulocytic populations by cytotoxicity testing. (1978) (13)
- A SENSITIVE IN VITRO MICROASSAY FOR DETECTING ANTIBODY‐DEPENDENT CELLULAR CYTOTOXICITY POSSIBLE ROLE IN MONITORING LYMPHOCYTE FUNCTION (1974) (13)
- Interspecies variability in antibody-dependent cellular cytotoxicity (ADCC). (1974) (11)
- Cord-blood-cell transplantation--a real sleeper? (1995) (10)
- Treatment of acute myelogenous leukemia in older patients. (1981) (7)
- A SENSITIVE METHOD FOR DETECTING ANTIBODIES IN HUMAN SERA USED FOR TISSUE TYPING (1974) (6)
- Further Aspects of Microgranulocytotoxicity (1979) (6)
- ZIO-101 (S-dimethylarsino-glutathione): Phase I/II trials in advanced/progressive multiple myeloma (2007) (6)
- Phase-1 trial of ZIO-101, a novel organic arsenic in patients with advanced cancers. (2006) (6)
- Dose-response effects of 4-hydroperoxycyclophosphamide on human T and B cell function in vitro. (1985) (6)
- Clinical uses of intravenous immunoglobulins. (1990) (5)
- Human lymphocytes subpopulations: rabbit red blood cell rosettes. (1977) (5)
- Hematopoietic engraftment following transplantation of bone marrow cells carrying a Philadelphia (Ph′)‐like chromosome (1977) (5)
- Protease nexin-1 prevents growth of human B cell lymphoma via inhibition of sonic hedgehog signaling (2018) (5)
- Costs of Chemotherapy for Indolent Follicular Non-Hodgkin’s Lymphoma in the UK: An Observational Study (2006) (4)
- Phase-1 study of isophosphoramide mustard (IPM)-lysine in advanced cancers. (2006) (4)
- Posttransfusion Hepatitis in Acute Myelogenous Leukemia-Reply (1981) (4)
- A phase 1 trial of a novel organic arsenic S-dimethylarsino-glutathione (ZIO-101) in hematological malignancies. (2006) (4)
- Mental Health in Persons With Chronic Myeloid Leukemia During the SARS-CoV-2 Pandemic: The Need for Increased Access to Health Care Services (2021) (3)
- ZIO-101, a Novel Organic Arsenic, Inhibits Human Myeloma Cell Growth in a SCID-hu Model. (2006) (3)
- Immunologic function in aplastic anemia. (1979) (3)
- Effects of Stress and Morphine on Natural Killer Cell Activity and on Mammary Tumor Development (1986) (3)
- Phase-1 Study of ZIO-101: A New Organic Arsenic Active in Acute Myelogenous Leukemia (AML) and Multiple Myeloma (MM). (2006) (3)
- Organic arsenic in patients (pts) with advanced solid tumors: Phase-1 results of zio-101 (s-dimethylarsino-glutathione) (2007) (2)
- lymphoma: myeloablative or reduced intensity? Conditioning regimens for allotransplants for diffuse large B-cell (2012) (1)
- Therapeutic Granulocyte Transfusions for Documented Infections (2020) (1)
- 479 POSTER ZIO-101: a new organic arsenic in advanced cancers (2006) (1)
- Human B-lymphocyte antigens expressed by lymphocytic and myelocytic leukemia cells: Lymphocyte-dependent antibody studies with rabbit antisera☆ (1977) (1)
- Treatment of Acute Myelogenous Leukemia (2020) (0)
- S-Dimethylarsinoglutathione (SGLU/ZIO101) Is a Novel Active Organic Arsenical That Displays a Unique Gene Expression Profile in Myeloma Cells. (2006) (0)
- Severe aplastic anaemia in a child with brachydactyly type c (2003) (0)
- Comparative Effects o f Three Dialkyldithiocarbamates on Acute Toxicity , Organ Distribution , and Excretion o (2015) (0)
- Correction: Study of Granulocyte Transfusion (1981) (0)
- Protease nexin-1 prevents growth of human B cell lymphoma via inhibition of sonic hedgehog signaling (2018) (0)
- Selective inhibitory effects of 4-hydroperoxycyclophosphamide (4-HCY) on T and B functions in man (1982) (0)
- Effects o f Combined Treatm ent with Diethyldithiocarbam ate and Diethylenetriam inepentaacetate on Organ Distribution and Excretion o (0)
- and Booster Tetanus Toxoid Immunization in Humans (1984) (0)
- [Autotransplantation in lymphomas: is it effective?]. (1992) (0)
This paper list is powered by the following services:
